Evaluating Learning Curves and Competence in Colorectal Endoscopic Mucosal Resection Among Advanced Endoscopy Trainees
Launched by ADVENTHEALTH · Apr 17, 2024
Trial Information
Current as of May 29, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the skills of advanced endoscopy trainees (AETs) who are learning to perform a procedure called colorectal endoscopic mucosal resection (EMR). EMR is a technique used to remove abnormal tissue from the colon. The study aims to establish how well these trainees are learning by using a standardized assessment tool. This will help set clear goals for what trainees should be able to do by certain points in their training, ensuring they develop the necessary skills and competence in performing this important procedure.
To participate in this study, AETs must be starting their advanced endoscopy fellowship training in 2022, regardless of their previous experience with colorectal EMR. Additionally, patients who are 18 years or older and are undergoing a colonoscopy with EMR performed by one of these trainees will also be involved in the study. Participants can expect that their experiences during the procedure will contribute to the training and evaluation of these future specialists, ultimately improving patient care in colorectal health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. All AETs from the participating centers starting their advanced endoscopy fellowship training in the academic year of 2022 (regardless of prior experience with colorectal EMR)
- • 2. Patients 18 years of age or older undergoing colonoscopy with EMR by the AET being evaluated for this study
- Exclusion Criteria:
- • 1. AETs in Advanced endoscopy programs that do not train AETs in colorectal EMR or AETs who do not intend to train in colorectal EMR during their fellowship will be excluded
About Adventhealth
AdventHealth is a comprehensive, faith-based healthcare organization dedicated to providing holistic care and advancing medical research through innovative clinical trials. With a commitment to improving patient outcomes and enhancing the quality of life, AdventHealth integrates cutting-edge technology and compassionate care across its extensive network of hospitals and outpatient facilities. The organization emphasizes a patient-centered approach, fostering collaboration among multidisciplinary teams to explore new treatment options and therapies. By participating in clinical research, AdventHealth aims to contribute to the advancement of medical knowledge and deliver transformative healthcare solutions to communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Orlando, Florida, United States
Patients applied
Trial Officials
Dennis Yang, MD
Principal Investigator
AdventHealth
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported